Suchergebnisse - "Lopinavir"

PubPharm (322)

1

A detailed characterization of drug resistance during darunavir/ritonavir monotherapy highlights a high barrier to the emergence of resistance mutations in protease but identifies alternative pathways of resistance

enthalten in: The Journal of antimicrobial chemotherapy | 2024

von Abdullahi, A. | Diaz, A. | Fopoussi, O. | +5

2

First Pharmacokinetic Data of Tenofovir Alafenamide Fumarate and Tenofovir With Dolutegravir or Boosted Protease Inhibitors in African Children : A Substudy of the CHAPAS-4 Trial

enthalten in: Clinical infectious diseases : an official publication of the Infectious Diseases Society of America | 2023

von Waalewijn, H. | Szubert, A. | Wasmann, R. | +18

3

Pharmacokinetics, Safety, and Bioequivalence of 2 Lopinavir/Ritonavir (200/50 mg) Tablets in Healthy Chinese Volunteers : Effect of Food on Absorption

enthalten in: Clinical pharmacology in drug development | 2023

von Zhang, W. | Lin, L. | Fu, W. | +5

4

Type I interferon autoantibodies in hospitalized patients with Middle East respiratory syndrome and association with outcomes and treatment effect of interferon beta-1b in MIRACLE clinical trial

enthalten in: Influenza and other respiratory viruses | 2023

von Alotaibi, F. | Alharbi, N. | Rosen, L. | +25

5

Lopinavir/ritonavir for treatment of non-hospitalized patients with COVID-19 : a randomized clinical trial

enthalten in: International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases | 2023

von Kaizer, A. | Shapiro, N. | Wild, J. | +13

6

Favipiravir, lopinavir-ritonavir, or combination therapy (FLARE) : A randomised, double-blind, 2 × 2 factorial placebo-controlled trial of early antiviral therapy in COVID-19

enthalten in: PLoS medicine | 2022

von Lowe, D. | Brown, L. | Chowdhury, K. | +15

7

An open-label randomized, controlled trial of the effect of lopinavir and ritonavir, lopinavir and ritonavir plus interferon-β-1a, and hydroxychloroquine in hospitalized patients with COVID-19 : final results

enthalten in: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases | 2022

von Ader, F. | DisCoVeRy Study Group

8

Should RECOVERY have used response adaptive randomisation? Evidence from a simulation study

enthalten in: BMC medical research methodology | 2022

von Sirkis, T. | Jones, B. | Bowden, J.

9

Efficacy and safety of favipiravir plus interferon-beta versus lopinavir/ritonavir plus interferon-beta in moderately ill patients with COVID-19 : A randomized clinical trial

enthalten in: Journal of medical virology | 2022

von Hassaniazad, M. | Farshidi, H. | Gharibzadeh, A. | +4

10

Brief Report : No Differences Between Lopinavir/Ritonavir and Nonnucleoside Reverse Transcriptase Inhibitor-Based Antiretroviral Therapy on Clearance of Plasmodium falciparum Subclinical Parasitemia in Adults Living With HIV Starting Treatment (A5297)

enthalten in: Journal of acquired immune deficiency syndromes (1999) | 2022

von Shaffer, D. | Kumwenda, J. | Chen, H. | +12

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[33]